Blood stream infections in patients in the burn intensive care unit
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, H.G. | - |
dc.contributor.author | Jang, J. | - |
dc.contributor.author | Choi, J.E. | - |
dc.contributor.author | Chung, D.C. | - |
dc.contributor.author | Han, J.W. | - |
dc.contributor.author | Woo, H. | - |
dc.contributor.author | Jeon, W. | - |
dc.contributor.author | Chun, B.C. | - |
dc.date.accessioned | 2021-09-06T10:07:05Z | - |
dc.date.available | 2021-09-06T10:07:05Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2093-2340 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/106023 | - |
dc.description.abstract | Background: The study on bacteremia helps empirically select the proper antibiotics before the results of culture test about causative pathogen. The purpose of this study is to investigate causative pathogen in bloodstream infection, changing aspects based on elapsed time after burn, relationship with other sites and resistance of important causative pathogen against antibiotics through analysis on bacteria isolated from blood culture of patients hospitalized in burn intensive care unit (BICU). Materials and Methods: A retrospective study was conducted targeting patients hospitalized in BICU from January 2007 to June 2011. Changes of causative pathogen in bloodstream infection based on elapsed time after injury were analyzed. We would like to examine the relationship between bloodstream infection and infection on other body parts by comparing results of cultures in burn wound site, sputum, urine and catheter tip. Antibiotics resistance patterns of Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus aureus, Enterococcus species, and Klebsiella pneumoniae were studied. Results: A total of 2,337 burn patients were hospitalized in BICU for 54 months. Causative pathogen was cultured in blood cultures from 397 patients (17.0%). P. aeruginosa (169, 30.1%) was the most cultured and A. baumannii (107, 19.0%) and S. aureus (81, 14.4%) were followed. It was confirmed that the relative frequency of A. baumannii tended to get lower as the period got longer after injury, but the relative frequency of K. pneumoniae got higher as the period got longer after injury. With comparison without bacteremia, P. aeruginosa bacteremia showed high probability in which the same bacteria were cultured in wound site, sputum and cathether tip, and A. baumannii bacteremia and candida bacteremia had high probability in sputum, and urine and catheter tip, respectively. 95.9% of P. aeruginosa and 95.3% of A. baumannii showed the resistance against carbapenem. 96.3% of S. aureus was methicillin resistant and 36.2% of Enterococcus species were vancomycin resistant. 75.0% of K. pneumonia were extended-spectrum beta-lactamase (ESBL)-producing bacteria. Conclusions: Since the highly antibiotic resistant microorganisms were isolated from the patients hospitalized in BICU during early phase, the empirical selection of antibiotics targeting these pathogens should be considered before the results of microbiologic culture test. In addition, use of empirical antifungal agent after 1 week of injury can be considered for patients who have risk factor of fungal infection. © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | antibiotic agent | - |
dc.subject | carbapenem | - |
dc.subject | extended spectrum beta lactamase | - |
dc.subject | meticillin | - |
dc.subject | sultamicillin | - |
dc.subject | vancomycin | - |
dc.subject | Acinetobacter baumannii | - |
dc.subject | adult | - |
dc.subject | antibiotic resistance | - |
dc.subject | antibiotic therapy | - |
dc.subject | article | - |
dc.subject | bacterial strain | - |
dc.subject | bacterium isolate | - |
dc.subject | blood culture | - |
dc.subject | bloodstream infection | - |
dc.subject | burn | - |
dc.subject | burn intensive care unit | - |
dc.subject | burn patient | - |
dc.subject | Candida | - |
dc.subject | candidiasis | - |
dc.subject | catheter | - |
dc.subject | controlled study | - |
dc.subject | Enterococcus | - |
dc.subject | extended spectrum beta lactamase producing Enterobacteriaceae | - |
dc.subject | female | - |
dc.subject | hospital patient | - |
dc.subject | human | - |
dc.subject | injury severity | - |
dc.subject | intensive care unit | - |
dc.subject | Klebsiella pneumoniae | - |
dc.subject | major clinical study | - |
dc.subject | male | - |
dc.subject | methicillin resistant Staphylococcus aureus | - |
dc.subject | pathogenesis | - |
dc.subject | patient selection | - |
dc.subject | Pseudomonas aeruginosa | - |
dc.subject | retrospective study | - |
dc.subject | risk factor | - |
dc.subject | sputum culture | - |
dc.subject | Staphylococcus aureus | - |
dc.subject | urine culture | - |
dc.title | Blood stream infections in patients in the burn intensive care unit | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Chun, B.C. | - |
dc.identifier.doi | 10.3947/ic.2013.45.2.194 | - |
dc.identifier.scopusid | 2-s2.0-84884235323 | - |
dc.identifier.bibliographicCitation | Infection and Chemotherapy, v.45, no.2, pp.194 - 201 | - |
dc.relation.isPartOf | Infection and Chemotherapy | - |
dc.citation.title | Infection and Chemotherapy | - |
dc.citation.volume | 45 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 194 | - |
dc.citation.endPage | 201 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001780546 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | antibiotic agent | - |
dc.subject.keywordPlus | carbapenem | - |
dc.subject.keywordPlus | extended spectrum beta lactamase | - |
dc.subject.keywordPlus | meticillin | - |
dc.subject.keywordPlus | sultamicillin | - |
dc.subject.keywordPlus | vancomycin | - |
dc.subject.keywordPlus | Acinetobacter baumannii | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | antibiotic resistance | - |
dc.subject.keywordPlus | antibiotic therapy | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | bacterial strain | - |
dc.subject.keywordPlus | bacterium isolate | - |
dc.subject.keywordPlus | blood culture | - |
dc.subject.keywordPlus | bloodstream infection | - |
dc.subject.keywordPlus | burn | - |
dc.subject.keywordPlus | burn intensive care unit | - |
dc.subject.keywordPlus | burn patient | - |
dc.subject.keywordPlus | Candida | - |
dc.subject.keywordPlus | candidiasis | - |
dc.subject.keywordPlus | catheter | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | Enterococcus | - |
dc.subject.keywordPlus | extended spectrum beta lactamase producing Enterobacteriaceae | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | hospital patient | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | injury severity | - |
dc.subject.keywordPlus | intensive care unit | - |
dc.subject.keywordPlus | Klebsiella pneumoniae | - |
dc.subject.keywordPlus | major clinical study | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | methicillin resistant Staphylococcus aureus | - |
dc.subject.keywordPlus | pathogenesis | - |
dc.subject.keywordPlus | patient selection | - |
dc.subject.keywordPlus | Pseudomonas aeruginosa | - |
dc.subject.keywordPlus | retrospective study | - |
dc.subject.keywordPlus | risk factor | - |
dc.subject.keywordPlus | sputum culture | - |
dc.subject.keywordPlus | Staphylococcus aureus | - |
dc.subject.keywordPlus | urine culture | - |
dc.subject.keywordAuthor | Blood stream infection | - |
dc.subject.keywordAuthor | Burn | - |
dc.subject.keywordAuthor | ICU | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.